Cambridge, MA – Blackstone Life Sciences (BXLS) announced a $455 million collaboration with Boston Scientific Corporation to co-fund the development of the VITALYST™ Temporary Percutaneous Transvalvular Circulatory Support System program. The...
Cambridge, MA – Blackstone Life Sciences (BXLS) announced a $455 million collaboration with Boston Scientific Corporation to co-fund the development of the VITALYST™ Temporary Percutaneous Transvalvular Circulatory Support System program. The...
The 563-patient blinded study found that HearO predicted more than 70% of heart failure events at an average of 24.6 days before they occurred, with high patient compliance and no device-related adverse events.
The 563-patient blinded study found that HearO predicted more than 70% of heart failure events at an average of 24.6 days before they occurred, with high patient compliance and no device-related adverse events.
Amgen announced results from a large real-world study showing that treatment with Repatha® (evolocumab) reduced the risk of fatal or nonfatal heart attacks by 20% compared with ezetimibe in people with atherosclerotic cardiovascular disease...
Amgen announced results from a large real-world study showing that treatment with Repatha® (evolocumab) reduced the risk of fatal or nonfatal heart attacks by 20% compared with ezetimibe in people with atherosclerotic cardiovascular disease...
Compared with usual care based on stress testing, care guided by AI-based quantitative coronary CT analysis (AI-QCT) improved diagnostic certainty and led to more patients receiving lipid-lowering therapy.
Compared with usual care based on stress testing, care guided by AI-based quantitative coronary CT analysis (AI-QCT) improved diagnostic certainty and led to more patients receiving lipid-lowering therapy.
Patients with acute myocardial infarction complicated by cardiogenic shock who received intravenous cangrelor had less microvascular obstruction and greater recovery of left ventricular function than those receiving crushed oral ticagrelor,...
Patients with acute myocardial infarction complicated by cardiogenic shock who received intravenous cangrelor had less microvascular obstruction and greater recovery of left ventricular function than those receiving crushed oral ticagrelor,...
Sub-analysis presented at TCT 2026 shows substantial clot burden reduction and improved right-heart function with the Symphony Thrombectomy System despite greater baseline cardiac stress in women
Sub-analysis presented at TCT 2026 shows substantial clot burden reduction and improved right-heart function with the Symphony Thrombectomy System despite greater baseline cardiac stress in women
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Benjamin Klein, DO; Sri Mandava, MD; Amre Ghazzal, MD; Karthik Vedantam, MD; Zsuzsanna Igyarto, PhD; Brad J. Martinsen, PhD; Ajay J. Kirtane, MD; Martin B. Leon, MD; Nirat Beohar, MD
This study compared acute and long-term outcomes between females and males undergoing orbital atherectomy in a real-world, high-risk cohort.
This study compared acute and long-term outcomes between females and males undergoing orbital atherectomy in a real-world, high-risk cohort.
The authors analyzed retrograde CTO PCI procedures from a multicenter registry to identify clinical, angiographic, and collateral-pathway factors associated with collateral channel crossing failure and to evaluate their association with...
The authors analyzed retrograde CTO PCI procedures from a multicenter registry to identify clinical, angiographic, and collateral-pathway factors associated with collateral channel crossing failure and to evaluate their association with...
The authors describe a simplified approach to the modified jailed balloon technique where postdilation is performed using only the stent delivery balloon, omitting proximal optimization, rewiring, and final kissing balloon inflation.
The authors describe a simplified approach to the modified jailed balloon technique where postdilation is performed using only the stent delivery balloon, omitting proximal optimization, rewiring, and final kissing balloon inflation.
A 70-year-old man had undergone mechanical mitral and aortic valve replacement in 2005 and redo mechanical mitral valve replacement in 2018 for prosthetic mitral valve dysfunction. In 2023, during hospitalization for lung abscess and...
A 70-year-old man had undergone mechanical mitral and aortic valve replacement in 2005 and redo mechanical mitral valve replacement in 2018 for prosthetic mitral valve dysfunction. In 2023, during hospitalization for lung abscess and...
A 60-year-old man who had previously undergone coronary artery bypass graft surgery presented with non-ST-segment elevation myocardial infarction. Angiography showed chronic total occlusion, diffuse left circumflex disease, patent left...
A 60-year-old man who had previously undergone coronary artery bypass graft surgery presented with non-ST-segment elevation myocardial infarction. Angiography showed chronic total occlusion, diffuse left circumflex disease, patent left...
Oscar Lagos Degrande, MD; Alicia Cinta Argandoña Garrido, RN; Felix Rosa Longobardo, MD; Carmen Lluch Requerey, MD; Elena Izaga, PhD; Santiago Camacho Freire, PhD; Jessica Roa Garrido, MD; Antonio Gomez Menchero, MD
A 64-year-old man with chronic ischemic heart disease presented with non-ST-elevation myocardial infarction, Killip Class I. His history included prior ST-elevation myocardial infarction in 2021 treated with everolimus-eluting stents to the...
A 64-year-old man with chronic ischemic heart disease presented with non-ST-elevation myocardial infarction, Killip Class I. His history included prior ST-elevation myocardial infarction in 2021 treated with everolimus-eluting stents to the...
Marios Tsourous, MD; Dimitrios Strepkos, MD; Theodoros Vichos, MD; Michaella Alexandrou, MD; Pedro E.P. Carvalho, MD; Ahmet Akyel, MD; Parth Desai, MD; Ayman Fath, MD; Sophie Macy, BS; James W. Choi, MD; Sevket Gorgulu, MD; Farouc A. Jaffer, MD; Raj Chandwaney, MD; Khaldoon Alaswad, MD; Mir B. Basir, MD; Lorenzo Azzalini, MD, PhD, MSc; Dmitrii Khelimskii, MD; Oleg Krestyaninov, MD; Laura Young, MD; Omer Goktekin, MD; Konstantinos Voudris, MD; Noah N. Williford, MD; Angie S. Lobo, MD; Yader Sandoval, MD; Emmanouil S. Brilakis, MD, PhD
The authors evaluated the clinical characteristics and procedural outcomes of dialysis patients undergoing chronic total occlusion percutaneous coronary intervention in a large, multicenter registry.
The authors evaluated the clinical characteristics and procedural outcomes of dialysis patients undergoing chronic total occlusion percutaneous coronary intervention in a large, multicenter registry.
The authors provide a striking visual demonstration of the anatomical and dynamic mechanisms underlying left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
The authors provide a striking visual demonstration of the anatomical and dynamic mechanisms underlying left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
James Leung, MBBS; John French, MBChB, PhD; James Xu, MBBS, PhD; Kathryn Wales, MD; Hashim Kachwalla, MBBS; Krishna Kaddapu, MBBS, PhD; Sarah Fares, MPhil; Viet Dang, MBBS; Tamer Badie, MBBS; Christian Mussap, MBBS, PhD; Rohan Rajaratnam, MBBS; Dominic Leung, MBBS, PhD; Sidney Lo, MBBS; Craig Juergens, MBBS, DMedSc
This study compared visual, robotic, and intracoronary imaging lesion length measurements performed during robotic-assisted percutaneous coronary intervention cases enrolled in the PARTY trial.
This study compared visual, robotic, and intracoronary imaging lesion length measurements performed during robotic-assisted percutaneous coronary intervention cases enrolled in the PARTY trial.